— Know what they know.
Not Investment Advice

DNLI NASDAQ

Denali Therapeutics Inc.
1W: -0.5% 1M: -4.7% 3M: -4.4% YTD: +18.6% 1Y: +35.1% 3Y: -34.1% 5Y: -64.2%
$18.64
-0.66 (-3.42%)
 
Weekly Expected Move ±7.0%
$16 $17 $19 $20 $21
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 35 · $3.0B mcap · 141M float · 1.22% daily turnover · Short 69% of daily vol
Last Earnings 2026-02-26
EPS
$-0.73
▲ Beat +2.7%
Revenue
$3M
Est (actual pending)
EPS Beat Streak: 3 quarters
Next Earnings 2026-08-10
EPS Estimate
$-0.59
Range: $-0.73 - $-0.54
Revenue Estimate
$23M
12 analysts

Estimate vs Actual

Earnings Surprise History

9/17
EPS Beats
5/17
Revenue Beats
53%
EPS Beat Rate
29%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-05-22 quarter 2026-09-30 $-0.59 $-0.59 $12,751,052 $12,751,052
2026-05-22 annual 2028-12-31 $-1.03 $-1.03 $422,410,374 $422,409,348
2026-05-22 annual 2026-12-31 $-2.46 $-2.46 $48,726,446 $48,728,962
2026-05-22 annual 2029-12-31 $-0.36 $-0.36 $561,398,598 $561,402,138
2026-05-22 annual 2027-12-31 $-2.45 $-2.45 $113,649,001 $113,647,148
2026-05-22 quarter 2026-06-30 $-0.59 $-0.59 $22,585,851 $22,585,851
2026-05-22 quarter 2026-12-31 $-0.68 $-0.68 $17,778,428 $17,781,083
2026-05-22 annual 2030-12-31 $0.95 $0.95 $868,414,059 $868,414,139
2026-05-18 quarter 2027-03-31 $-0.72 $-0.70 ▲ 0.02 $14,294,828 $14,294,828
2026-05-18 quarter 2028-12-31 $0.14 $0.12 ▼ 0.02 $222,350,379 $222,350,379
2026-05-18 annual 2027-12-31 $-2.46 $-2.45 ▲ 0.01 $113,649,001 $113,649,001
2026-05-18 quarter 2026-06-30 $-0.60 $-0.59 ▲ 0.01 $22,585,851 $22,585,851
2026-05-18 quarter 2028-03-31 $-0.27 $-0.25 ▲ 0.02 $125,193,547 $125,193,547
2026-05-18 quarter 2028-06-30 $-0.13 $-0.12 ▲ 0.01 $157,345,838 $157,345,838
2026-05-18 annual 2028-12-31 $-1.03 $-1.03 $422,410,374 $422,410,374
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms